The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature

B. O. Olusanya, F. B. Osibanjo, C. A. Mabogunje, T. M. Slusher, S. A. Olowe

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Neonatal jaundice is a leading cause of hospitalization in the first week of life worldwide. If inappropriately managed, it may result in significant bilirubin-induced mortality and disability. We set out to describe the epidemiology of neonatal hyperbilirubinemia as well as the practices and challenges in the care of infants with significant neonatal hyperbilirubinemia (SNH) in Nigeria, as basis for policy intervention and research priorities. We systematically searched PubMed, Scopus, EMBASE, Cumulative Index to Nursing and Allied Health Literature, WHO Library Database, African Index Medicus, African Journals Online, and local journals for studies published between January 1960 and December 2014. We included studies, without restriction on methodological design that provided evidence on the incidence/prevalence, etiological /risk factors and adverse outcomes of hyperbilirubinemia, care-seeking practices, diagnosis and treatment, as well as follow-up evaluation of infants with SNH in Nigeria. A total of 558 studies were identified from all sources out of which 198 (35.5%) were finally selected. SNH accounted for about one in five neonatal admissions and has been associated consistently with substantial case fatality and neuro-developmental sequelae such as cerebral palsy and auditory impairments, especially among out-born babies. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, prematurity/low birth weight, infection, and ABO incompatibility were most frequently, and Rhesus disease rarely, associated with SNH. Late presentation at appropriate health facilities was common and resulted in high rates of acute bilirubin encephalopathy (ABE), kernicterus and avoidable exchange transfusions. Uniform practice guidelines, including developmental assessment and surveillance of infants with SNH, were rare at all levels of healthcare delivery. In summary, since 1960, SHN persists as a major contributor to neonatal mortality and developmental disabilities in Nigeria. The underpinning maternal, perinatal and neonatal factors as well as systems-based constraints are not insurmountable. Systematic and sustained interventions are warranted to curtail the disproportionate and perennial burden of this condition in this population.

Original languageEnglish (US)
Pages (from-to)1-17
Number of pages17
JournalNigerian Journal of Clinical Practice
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Neonatal Hyperbilirubinemia
Neonatal Jaundice
Nigeria
Kernicterus
Glucosephosphate Dehydrogenase Deficiency
Infant Care
Developmental Disabilities
Hyperbilirubinemia
Health Facilities
Infant Mortality
Low Birth Weight Infant
Cerebral Palsy
Bilirubin
Practice Guidelines
PubMed
MEDLINE
Libraries
Epidemiology
Hospitalization
Nursing

Keywords

  • Etiology
  • bilirubin-encephalopathy
  • care-seeking behavior
  • developing country
  • developmental disabilities
  • kernicterus
  • newborn care
  • risk factors

Cite this

The burden and management of neonatal jaundice in Nigeria : A scoping review of the literature. / Olusanya, B. O.; Osibanjo, F. B.; Mabogunje, C. A.; Slusher, T. M.; Olowe, S. A.

In: Nigerian Journal of Clinical Practice, Vol. 19, No. 1, 01.01.2016, p. 1-17.

Research output: Contribution to journalReview article

Olusanya, B. O. ; Osibanjo, F. B. ; Mabogunje, C. A. ; Slusher, T. M. ; Olowe, S. A. / The burden and management of neonatal jaundice in Nigeria : A scoping review of the literature. In: Nigerian Journal of Clinical Practice. 2016 ; Vol. 19, No. 1. pp. 1-17.
@article{e88653611aaa4f20b02af620cf9136c8,
title = "The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature",
abstract = "Neonatal jaundice is a leading cause of hospitalization in the first week of life worldwide. If inappropriately managed, it may result in significant bilirubin-induced mortality and disability. We set out to describe the epidemiology of neonatal hyperbilirubinemia as well as the practices and challenges in the care of infants with significant neonatal hyperbilirubinemia (SNH) in Nigeria, as basis for policy intervention and research priorities. We systematically searched PubMed, Scopus, EMBASE, Cumulative Index to Nursing and Allied Health Literature, WHO Library Database, African Index Medicus, African Journals Online, and local journals for studies published between January 1960 and December 2014. We included studies, without restriction on methodological design that provided evidence on the incidence/prevalence, etiological /risk factors and adverse outcomes of hyperbilirubinemia, care-seeking practices, diagnosis and treatment, as well as follow-up evaluation of infants with SNH in Nigeria. A total of 558 studies were identified from all sources out of which 198 (35.5{\%}) were finally selected. SNH accounted for about one in five neonatal admissions and has been associated consistently with substantial case fatality and neuro-developmental sequelae such as cerebral palsy and auditory impairments, especially among out-born babies. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, prematurity/low birth weight, infection, and ABO incompatibility were most frequently, and Rhesus disease rarely, associated with SNH. Late presentation at appropriate health facilities was common and resulted in high rates of acute bilirubin encephalopathy (ABE), kernicterus and avoidable exchange transfusions. Uniform practice guidelines, including developmental assessment and surveillance of infants with SNH, were rare at all levels of healthcare delivery. In summary, since 1960, SHN persists as a major contributor to neonatal mortality and developmental disabilities in Nigeria. The underpinning maternal, perinatal and neonatal factors as well as systems-based constraints are not insurmountable. Systematic and sustained interventions are warranted to curtail the disproportionate and perennial burden of this condition in this population.",
keywords = "Etiology, bilirubin-encephalopathy, care-seeking behavior, developing country, developmental disabilities, kernicterus, newborn care, risk factors",
author = "Olusanya, {B. O.} and Osibanjo, {F. B.} and Mabogunje, {C. A.} and Slusher, {T. M.} and Olowe, {S. A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.4103/1119-3077.173703",
language = "English (US)",
volume = "19",
pages = "1--17",
journal = "Nigerian Journal of Clinical Practice",
issn = "1119-3077",
publisher = "Medical and Dental Consultants Association of Nigeria (MDCAN)",
number = "1",

}

TY - JOUR

T1 - The burden and management of neonatal jaundice in Nigeria

T2 - A scoping review of the literature

AU - Olusanya, B. O.

AU - Osibanjo, F. B.

AU - Mabogunje, C. A.

AU - Slusher, T. M.

AU - Olowe, S. A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Neonatal jaundice is a leading cause of hospitalization in the first week of life worldwide. If inappropriately managed, it may result in significant bilirubin-induced mortality and disability. We set out to describe the epidemiology of neonatal hyperbilirubinemia as well as the practices and challenges in the care of infants with significant neonatal hyperbilirubinemia (SNH) in Nigeria, as basis for policy intervention and research priorities. We systematically searched PubMed, Scopus, EMBASE, Cumulative Index to Nursing and Allied Health Literature, WHO Library Database, African Index Medicus, African Journals Online, and local journals for studies published between January 1960 and December 2014. We included studies, without restriction on methodological design that provided evidence on the incidence/prevalence, etiological /risk factors and adverse outcomes of hyperbilirubinemia, care-seeking practices, diagnosis and treatment, as well as follow-up evaluation of infants with SNH in Nigeria. A total of 558 studies were identified from all sources out of which 198 (35.5%) were finally selected. SNH accounted for about one in five neonatal admissions and has been associated consistently with substantial case fatality and neuro-developmental sequelae such as cerebral palsy and auditory impairments, especially among out-born babies. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, prematurity/low birth weight, infection, and ABO incompatibility were most frequently, and Rhesus disease rarely, associated with SNH. Late presentation at appropriate health facilities was common and resulted in high rates of acute bilirubin encephalopathy (ABE), kernicterus and avoidable exchange transfusions. Uniform practice guidelines, including developmental assessment and surveillance of infants with SNH, were rare at all levels of healthcare delivery. In summary, since 1960, SHN persists as a major contributor to neonatal mortality and developmental disabilities in Nigeria. The underpinning maternal, perinatal and neonatal factors as well as systems-based constraints are not insurmountable. Systematic and sustained interventions are warranted to curtail the disproportionate and perennial burden of this condition in this population.

AB - Neonatal jaundice is a leading cause of hospitalization in the first week of life worldwide. If inappropriately managed, it may result in significant bilirubin-induced mortality and disability. We set out to describe the epidemiology of neonatal hyperbilirubinemia as well as the practices and challenges in the care of infants with significant neonatal hyperbilirubinemia (SNH) in Nigeria, as basis for policy intervention and research priorities. We systematically searched PubMed, Scopus, EMBASE, Cumulative Index to Nursing and Allied Health Literature, WHO Library Database, African Index Medicus, African Journals Online, and local journals for studies published between January 1960 and December 2014. We included studies, without restriction on methodological design that provided evidence on the incidence/prevalence, etiological /risk factors and adverse outcomes of hyperbilirubinemia, care-seeking practices, diagnosis and treatment, as well as follow-up evaluation of infants with SNH in Nigeria. A total of 558 studies were identified from all sources out of which 198 (35.5%) were finally selected. SNH accounted for about one in five neonatal admissions and has been associated consistently with substantial case fatality and neuro-developmental sequelae such as cerebral palsy and auditory impairments, especially among out-born babies. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, prematurity/low birth weight, infection, and ABO incompatibility were most frequently, and Rhesus disease rarely, associated with SNH. Late presentation at appropriate health facilities was common and resulted in high rates of acute bilirubin encephalopathy (ABE), kernicterus and avoidable exchange transfusions. Uniform practice guidelines, including developmental assessment and surveillance of infants with SNH, were rare at all levels of healthcare delivery. In summary, since 1960, SHN persists as a major contributor to neonatal mortality and developmental disabilities in Nigeria. The underpinning maternal, perinatal and neonatal factors as well as systems-based constraints are not insurmountable. Systematic and sustained interventions are warranted to curtail the disproportionate and perennial burden of this condition in this population.

KW - Etiology

KW - bilirubin-encephalopathy

KW - care-seeking behavior

KW - developing country

KW - developmental disabilities

KW - kernicterus

KW - newborn care

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=84955470825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955470825&partnerID=8YFLogxK

U2 - 10.4103/1119-3077.173703

DO - 10.4103/1119-3077.173703

M3 - Review article

C2 - 26755212

AN - SCOPUS:84955470825

VL - 19

SP - 1

EP - 17

JO - Nigerian Journal of Clinical Practice

JF - Nigerian Journal of Clinical Practice

SN - 1119-3077

IS - 1

ER -